Keefe, Bruyette & Woods Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $13

Benzinga Newsdesk www.benzinga.com Negative 93.8%

Neg 93.8% Neu 0% Pos 0%

Keefe, Bruyette & Woods analyst Paul Johnson maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $15 to $13.